Strive Medical (“Strive” or the “Company”), a portfolio company of NMS Capital (“NMS”), announces the acquisition of ProMed DME, LLC (“ProMed DME” or the “Company”), a durable medical equipment (“DME”) provider specializing in diabetic continuous glucose monitoring (CGM) supplies. “This transaction is a crucial milestone in Strive Medical’s dedication to investing in growth markets and delivering our unique offerings to patients in rapidly expanding disease areas,” said Todd Philbrick, CEO of Strive. “We are excited to collaborate with the ProMed team, known for their patient-first approach, and to enhance our commercial reach. This next chapter for Strive broadens our presence in the healthcare ecosystem. Strive Medical plans to operate ProMed DME as a Diabetes Center of Excellence, continuing to support the patients who rely on us.”
Read the full article: Strive Medical Announces Acquisition of ProMed DME, LLC //
Source: https://nms-capital.com/news/strive-medical-announces-acquisition-promed-dme/